Biotech Values

[DewDiligence]

>I agree with your statement. And your "why" is well stated. However, being "inconsistent" will not destroy the clinical trial system, IMHO. Drug trials face that same problem today when the drug at issue is approved for other uses or there are reasonable alternative drugs.<

I respectfully disagree. The difficulties companies face enrolling clinical trials today would be immensely greater, IMO, if the Abigail Aliance’s demands became government policy.